SENATE, No. 3707 STATE OF NEW JERSEY 221st LEGISLATURE INTRODUCED SEPTEMBER 30, 2024
SENATE, No. 3707
STATE OF NEW JERSEY
221st LEGISLATURE
INTRODUCED SEPTEMBER 30, 2024
Sponsored by: Senator JOSEPH F. VITALE District 19 (Middlesex) SYNOPSIS Revises statutory definition of "elevated blood lead level." CURRENT VERSION OF TEXT As introduced.
Sponsored by:
Senator JOSEPH F. VITALE
District 19 (Middlesex)
SYNOPSIS
Revises statutory definition of "elevated blood lead level."
CURRENT VERSION OF TEXT
As introduced.
An Act concerning elevated blood lead levels and amending P.L.1995, c.328. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. Section 2 of P.L.1995, c.328 (C.26:2-137.3) is amended to read as follows: 2. As used in this act: "Commissioner" means the Commissioner of Health. "Department" means the Department of Health. "Elevated blood lead level" means a level of lead in the bloodstream that equals or exceeds [five] 3.5 micrograms per deciliter or other such amount as may be identified in the most recent recommendations from the federal Centers for Disease Control and Prevention, and that necessitates the undertaking of responsive action. "Lead poisoning" means the poisoning of the bloodstream that results from prolonged exposure to lead or lead-based substances in water, paint, building materials, or the environment, and which causes uncorrectable developmental delay and decreased mental functioning capacity in children, and in severe cases, can lead to a child's premature death. "Lead screening" means the application of a detection technique to measure a child's blood lead level and determine the extent of a child's recent exposure to lead. (cf: P.L.2017, c.7, s.4) 2. This act shall take effect immediately. STATEMENT This bill revises the statutory definition of "elevated blood lead level." Under current law, "elevated blood lead level" is defined to mean a level of lead in the bloodstream that equals or exceeds five micrograms per deciliter. This bill revises the definition of "elevated blood lead level" to mean a level of lead in the bloodstream that equals or exceeds 3.5 micrograms per deciliter.
An Act concerning elevated blood lead levels and amending P.L.1995, c.328.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. Section 2 of P.L.1995, c.328 (C.26:2-137.3) is amended to read as follows:
2. As used in this act:
"Commissioner" means the Commissioner of Health.
"Department" means the Department of Health.
"Elevated blood lead level" means a level of lead in the bloodstream that equals or exceeds [five] 3.5 micrograms per deciliter or other such amount as may be identified in the most recent recommendations from the federal Centers for Disease Control and Prevention, and that necessitates the undertaking of responsive action.
"Lead poisoning" means the poisoning of the bloodstream that results from prolonged exposure to lead or lead-based substances in water, paint, building materials, or the environment, and which causes uncorrectable developmental delay and decreased mental functioning capacity in children, and in severe cases, can lead to a child's premature death.
"Lead screening" means the application of a detection technique to measure a child's blood lead level and determine the extent of a child's recent exposure to lead.
(cf: P.L.2017, c.7, s.4)
2. This act shall take effect immediately.
STATEMENT
This bill revises the statutory definition of "elevated blood lead level." Under current law, "elevated blood lead level" is defined to mean a level of lead in the bloodstream that equals or exceeds five micrograms per deciliter. This bill revises the definition of "elevated blood lead level" to mean a level of lead in the bloodstream that equals or exceeds 3.5 micrograms per deciliter.